European CEO interviews Lars-Erik Eriksson, CEO at CLS

Lars-Erik Eriksson CEO at Clinical Laserthermia Systems, was in the beginning of the year awarded the European CEO Awards 2016 as ”Best CEO in The Medical Device Industry”. As part of the prize ceremony an interview took place in a studio at the London Stock Exchange.

See the interview

Read more about European CEO Awards 

Lars-Erik Eriksson, CEO, Clinical Laserthermia Systems AB (publ)
Tel: +46 – (0)702 – 90 33 00   E-mail:

Clinical Laserthermia Systems AB (publ), develops and sells the TRANBERG®|Thermal Therapy System and specially designed sterile disposable products for safe, gentle and effective treatment of cancerous tumors. The products are marketed for image-guided laser ablation and for treatment with immunostimulating interstitial laser thermotherapy, imILT®. The company, which is headquartered in Lund Sweden and has a subsidiary in Boston, MA, is listed Nasdaq First North under the ticker CLS B. Certified Adviser is Västra Hamnen Corporate Finance. Further information is available on the company’s websites: